{"transactions":[{"id":3444654,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-07T19:20:48.000Z","date":"2019-08-06","kind":"tax_withholding","acquired":false,"shares":1641,"price":0.21,"value":344.61,"ownership":{"direct":true},"balance_after":403893,"source":{"system":"sec-edgar","filing":"0001144204-19-038331","document":"tv527073_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420419038331/tv527073_4.xml","form_type":"4"}},{"id":3461931,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-15T20:38:25.000Z","date":"2019-07-15","kind":"sale","acquired":false,"shares":6488,"price":0.233,"value":1511.704,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.227 to $0.2403, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."}],"balance_after":405534,"source":{"system":"sec-edgar","filing":"0001144204-19-034764","document":"tv525230_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420419034764/tv525230_4.xml","form_type":"4"}},{"id":3461930,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-15T20:38:25.000Z","date":"2019-07-12","kind":"sale","acquired":false,"shares":6488,"price":0.2356,"value":1528.5728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2257 to $0.24, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":412022,"source":{"system":"sec-edgar","filing":"0001144204-19-034764","document":"tv525230_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420419034764/tv525230_4.xml","form_type":"4"}},{"id":3461929,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-15T20:38:25.000Z","date":"2019-07-11","kind":"sale","acquired":false,"shares":6487,"price":0.2406,"value":1560.7722,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.24 to $0.245, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":418510,"source":{"system":"sec-edgar","filing":"0001144204-19-034764","document":"tv525230_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420419034764/tv525230_4.xml","form_type":"4"}},{"id":3674445,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T16:36:36.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2020, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":50000,"derivative":{"exercise_price":0.48,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-19-005042","document":"tv512442_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420419005042/tv512442_form4.xml","form_type":"4"}},{"id":3868728,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-12T16:49:48.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to one-third (1/3) of the shares on July 10, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":424997,"source":{"system":"sec-edgar","filing":"0001144204-18-038180","document":"tv498473_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420418038180/tv498473_4.xml","form_type":"4"}},{"id":3895552,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-13T16:32:26.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":7000,"price":0.54,"value":3780.0,"ownership":{"direct":false,"nature":"By husband"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 previously filed on June 11, 2018 inadvertently misclassified the 2,215 shares purchased on June 7, 2018 and 7,000 shares purchased on June 8, 2018 as being beneficially owned directly by the reporting person instead of indirectly, and inadvertently omitted the purchase of 9,600 shares by the reporting person on June 7, 2018, which are beneficially owned directly. This amendment corrects that error to add the omitted transaction from June 7, 2018 and to reflect the correct number of shares beneficially owned by the reporting person, both directly and indirectly, after the reported transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Form 4 previously filed on June 11, 2018 inadvertently misclassified the 2,215 shares purchased on June 7, 2018 and 7,000 shares purchased on June 8, 2018 as being beneficially owned directly by the reporting person instead of indirectly, and inadvertently omitted the purchase of 9,600 shares by the reporting person on June 7, 2018, which are beneficially owned directly. This amendment corrects that error to add the omitted transaction from June 7, 2018 and to reflect the correct number of shares beneficially owned by the reporting person, both directly and indirectly, after the reported transaction."}],"balance_after":59915,"source":{"system":"sec-edgar","filing":"0001144204-18-034065","document":"tv496443_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420418034065/tv496443_4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3895551,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-13T16:32:26.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":9600,"price":0.52,"value":4992.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 previously filed on June 11, 2018 inadvertently misclassified the 2,215 shares purchased on June 7, 2018 and 7,000 shares purchased on June 8, 2018 as being beneficially owned directly by the reporting person instead of indirectly, and inadvertently omitted the purchase of 9,600 shares by the reporting person on June 7, 2018, which are beneficially owned directly. This amendment corrects that error to add the omitted transaction from June 7, 2018 and to reflect the correct number of shares beneficially owned by the reporting person, both directly and indirectly, after the reported transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Form 4 previously filed on June 11, 2018 inadvertently misclassified the 2,215 shares purchased on June 7, 2018 and 7,000 shares purchased on June 8, 2018 as being beneficially owned directly by the reporting person instead of indirectly, and inadvertently omitted the purchase of 9,600 shares by the reporting person on June 7, 2018, which are beneficially owned directly. This amendment corrects that error to add the omitted transaction from June 7, 2018 and to reflect the correct number of shares beneficially owned by the reporting person, both directly and indirectly, after the reported transaction."}],"balance_after":249997,"source":{"system":"sec-edgar","filing":"0001144204-18-034065","document":"tv496443_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420418034065/tv496443_4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3895550,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-13T16:32:26.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":2215,"price":0.52,"value":1151.8,"ownership":{"direct":false,"nature":"By husband"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 previously filed on June 11, 2018 inadvertently misclassified the 2,215 shares purchased on June 7, 2018 and 7,000 shares purchased on June 8, 2018 as being beneficially owned directly by the reporting person instead of indirectly, and inadvertently omitted the purchase of 9,600 shares by the reporting person on June 7, 2018, which are beneficially owned directly. This amendment corrects that error to add the omitted transaction from June 7, 2018 and to reflect the correct number of shares beneficially owned by the reporting person, both directly and indirectly, after the reported transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Form 4 previously filed on June 11, 2018 inadvertently misclassified the 2,215 shares purchased on June 7, 2018 and 7,000 shares purchased on June 8, 2018 as being beneficially owned directly by the reporting person instead of indirectly, and inadvertently omitted the purchase of 9,600 shares by the reporting person on June 7, 2018, which are beneficially owned directly. This amendment corrects that error to add the omitted transaction from June 7, 2018 and to reflect the correct number of shares beneficially owned by the reporting person, both directly and indirectly, after the reported transaction."}],"balance_after":52915,"source":{"system":"sec-edgar","filing":"0001144204-18-034065","document":"tv496443_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420418034065/tv496443_4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3898500,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-11T20:37:21.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":7000,"price":0.54,"value":3780.0,"ownership":{"direct":true},"balance_after":249612,"source":{"system":"sec-edgar","filing":"0001144204-18-033815","document":"tv496312_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420418033815/tv496312_form4.xml","form_type":"4"}},{"id":3898499,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-11T20:37:21.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":2215,"price":0.52,"value":1151.8,"ownership":{"direct":true},"balance_after":242612,"source":{"system":"sec-edgar","filing":"0001144204-18-033815","document":"tv496312_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420418033815/tv496312_form4.xml","form_type":"4"}},{"id":4023987,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T16:13:20.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 28, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":25000,"derivative":{"exercise_price":0.57,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-18-012235","document":"tv487518_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420418012235/tv487518_4.xml","form_type":"4"}},{"id":4112397,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-03T16:07:58.000Z","date":"2017-12-29","kind":"other","acquired":true,"shares":12355,"price":1.01,"value":12478.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's Employee Stock Purchase Plan on December 29, 2017 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":240397,"source":{"system":"sec-edgar","filing":"0001144204-18-000497","document":"tv482538_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420418000497/tv482538_4.xml","form_type":"4"}},{"id":4208394,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-15T16:29:46.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":9000,"price":1.2,"value":10800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.19 to $1.21, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":228042,"source":{"system":"sec-edgar","filing":"0001144204-17-048266","document":"v475305_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420417048266/v475305_4.xml","form_type":"4"}},{"id":4208393,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-15T16:29:46.000Z","date":"2017-09-14","kind":"grant","acquired":true,"shares":9000,"price":1.23,"value":11070.0,"ownership":{"direct":false,"nature":"By husband"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.24, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":50700,"source":{"system":"sec-edgar","filing":"0001144204-17-048266","document":"v475305_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420417048266/v475305_4.xml","form_type":"4"}},{"id":4208392,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-15T16:29:46.000Z","date":"2017-09-14","kind":"grant","acquired":true,"shares":1200,"price":1.22,"value":1464.0,"ownership":{"direct":true},"balance_after":219042,"source":{"system":"sec-edgar","filing":"0001144204-17-048266","document":"v475305_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420417048266/v475305_4.xml","form_type":"4"}},{"id":4274626,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T16:24:02.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on June 21, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":35000,"derivative":{"exercise_price":1.35,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-17-033632","document":"v469456_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420417033632/v469456_4.xml","form_type":"4"}},{"id":4397636,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-07T17:52:09.000Z","date":"2017-03-07","kind":"grant","acquired":true,"shares":8700,"price":2.83,"value":24621.0,"ownership":{"direct":true},"balance_after":217842,"source":{"system":"sec-edgar","filing":"0001144204-17-013286","document":"v461341_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420417013286/v461341_4.xml","form_type":"4"}},{"id":4414277,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-01T17:25:22.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":41700,"price":2.6,"value":108420.0,"ownership":{"direct":false,"nature":"By husband"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $2.55 to $2.69, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":41700,"source":{"system":"sec-edgar","filing":"0001144204-17-012198","document":"v460907_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420417012198/v460907_4.xml","form_type":"4"}},{"id":4414276,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-01T17:25:22.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":54200,"price":2.59,"value":140378.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $2.55 to $2.70, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":209142,"source":{"system":"sec-edgar","filing":"0001144204-17-012198","document":"v460907_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420417012198/v460907_4.xml","form_type":"4"}},{"id":4464149,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":155602,"kind":"person","name":"Wirostko Barbara","position":1,"cik":"0001669087","reported_name":"Wirostko Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-07T16:16:07.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to one-third (1/3) of the shares on February 6, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":154942,"source":{"system":"sec-edgar","filing":"0001144204-17-006501","document":"v458599_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669087/000114420417006501/v458599_4.xml","form_type":"4"}}]}